| Product Code: ETC13347097 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Precision Genomic Testing Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Precision Genomic Testing Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Precision Genomic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 North America Precision Genomic Testing Market - Industry Life Cycle |
3.4 North America Precision Genomic Testing Market - Porter's Five Forces |
3.5 North America Precision Genomic Testing Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Precision Genomic Testing Market Revenues & Volume Share, By Testing Type, 2021 & 2031F |
3.7 North America Precision Genomic Testing Market Revenues & Volume Share, By Application Area, 2021 & 2031F |
3.8 North America Precision Genomic Testing Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.9 North America Precision Genomic Testing Market Revenues & Volume Share, By Service Type, 2021 & 2031F |
4 North America Precision Genomic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Precision Genomic Testing Market Trends |
6 North America Precision Genomic Testing Market, 2021 - 2031 |
6.1 North America Precision Genomic Testing Market, Revenues & Volume, By Testing Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Precision Genomic Testing Market, Revenues & Volume, By Cancer Testing, 2021 - 2031 |
6.1.3 North America Precision Genomic Testing Market, Revenues & Volume, By Prenatal Testing, 2021 - 2031 |
6.1.4 North America Precision Genomic Testing Market, Revenues & Volume, By Pharmacogenomics, 2021 - 2031 |
6.1.5 North America Precision Genomic Testing Market, Revenues & Volume, By Whole Genome Sequencing, 2020 - 2028 |
6.2 North America Precision Genomic Testing Market, Revenues & Volume, By Application Area, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Precision Genomic Testing Market, Revenues & Volume, By Rare Genetic Disorders, 2021 - 2031 |
6.2.3 North America Precision Genomic Testing Market, Revenues & Volume, By Cardiovascular Diseases, 2021 - 2031 |
6.2.4 North America Precision Genomic Testing Market, Revenues & Volume, By Infectious Diseases, 2021 - 2031 |
6.2.5 North America Precision Genomic Testing Market, Revenues & Volume, By Neurological Disorders, 2021 - 2031 |
6.3 North America Precision Genomic Testing Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Precision Genomic Testing Market, Revenues & Volume, By Next-Generation Sequencing, 2021 - 2031 |
6.3.3 North America Precision Genomic Testing Market, Revenues & Volume, By PCR Testing, 2021 - 2031 |
6.3.4 North America Precision Genomic Testing Market, Revenues & Volume, By CRISPR Testing, 2021 - 2031 |
6.3.5 North America Precision Genomic Testing Market, Revenues & Volume, By Sanger Sequencing, 2021 - 2031 |
6.4 North America Precision Genomic Testing Market, Revenues & Volume, By Service Type, 2021 - 2031 |
6.4.2 North America Precision Genomic Testing Market, Revenues & Volume, By Diagnostic Services, 2021 - 2031 |
6.4.3 North America Precision Genomic Testing Market, Revenues & Volume, By In-House Testing, 2021 - 2031 |
6.4.4 North America Precision Genomic Testing Market, Revenues & Volume, By Third-Party Testing, 2020 - 2028 |
6.4.5 North America Precision Genomic Testing Market, Revenues & Volume, By Laboratory Services, 2020 - 2028 |
7 North America Precision Genomic Testing Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Precision Genomic Testing Market, Revenues & Volume, By Testing Type, 2021 - 2031 |
7.2.1 United States (US) Precision Genomic Testing Market, Revenues & Volume, By Testing Type, 2021 - 2031 |
7.2.2 Canada Precision Genomic Testing Market, Revenues & Volume, By Testing Type, 2021 - 2031 |
7.2.3 Rest of North America Precision Genomic Testing Market, Revenues & Volume, By Testing Type, 2021 - 2031 |
7.3 North America Precision Genomic Testing Market Revenues & Volume Share, By Application Area, 2021 & 2031F |
7.3.1 United States (US) Precision Genomic Testing Market, Revenues & Volume, By Application Area, 2021 - 2031 |
7.3.2 Canada Precision Genomic Testing Market, Revenues & Volume, By Application Area, 2021 - 2031 |
7.3.3 Rest of North America Precision Genomic Testing Market, Revenues & Volume, By Application Area, 2021 - 2031 |
7.4 North America Precision Genomic Testing Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.4.1 United States (US) Precision Genomic Testing Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.4.2 Canada Precision Genomic Testing Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.4.3 Rest of North America Precision Genomic Testing Market, Revenues & Volume, By Technology Type, 2021 - 2031 |
7.5 North America Precision Genomic Testing Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.5.1 United States (US) Precision Genomic Testing Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.5.2 Canada Precision Genomic Testing Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.5.3 Rest of North America Precision Genomic Testing Market, Revenues & Volume, By Service Type, 2021 - 2031 |
8 North America Precision Genomic Testing Market Key Performance Indicators |
9 North America Precision Genomic Testing Market - Export/Import By Countries Assessment |
10 North America Precision Genomic Testing Market - Opportunity Assessment |
10.1 North America Precision Genomic Testing Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Precision Genomic Testing Market Opportunity Assessment, By Testing Type, 2021 & 2031F |
10.3 North America Precision Genomic Testing Market Opportunity Assessment, By Application Area, 2021 & 2031F |
10.4 North America Precision Genomic Testing Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
10.5 North America Precision Genomic Testing Market Opportunity Assessment, By Service Type, 2021 & 2031F |
11 North America Precision Genomic Testing Market - Competitive Landscape |
11.1 North America Precision Genomic Testing Market Revenue Share, By Companies, 2022 |
11.2 North America Precision Genomic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here